Amplifications of RTKs such as EGFR (epidermal growth factor receptor) and FGFR1 (fibroblast growth factor receptor 1) are frequently observed in breast cancers that do not respond to ET [8]. This evidence concerns the gene FGFR1 and breast cancer.